FREMONT, Calif., July 09, 2024 (GLOBE NEWSWIRE) -- Paragon Genomics, a California-based leader in advanced amplicon-based target enrichment solutions for next-generation sequencing (NGS) and precision medicine, today announced an agreement with Biosecure ID to distribute its CleanPlex® products and technology in the United Kingdom and the Republic of Ireland. CleanPlex is a proprietary, ultra-high multiplexed target enrichment technology for NGS-based assays for research and diagnostic testing. Biosecure ID, a new UK-based value-added reseller with expertise in applied genomics, is a for-profit unit of Science Social for Good CIC, an organization dedicated to expanding the availability of locally based genetic research and testing services globally.Tao Chen, Chief Executive Officer of Paragon Genomics, said, “This agreement with the DNA testing visionaries at Biosecure ID caps a year in which we have been expanding the reach of our CleanPlex® products and services via new relationships with a diverse group of distributors serving territories around the globe, including Asia, Europe, Africa and Central America. The UK and Ireland with their advanced life sciences research and clinical communities represent substantial markets for our unique technology, which provides highly advanced and robust targeted resequencing solutions that are easy to use. We look forward to working with the experienced genomics industry experts at Biosecure ID to increase the availability of CleanPlex® products and services in Britain and Ireland and further our mission of advancing precision medicine.”Yogesh Prasad, PhD, MBA, a Co-founder and Director of Biosecure ID, commented, ”As a value-added reseller embodying both a mission and substantial genomics expertise, we are very pleased to partner with Paragon Genomics in the UK and Ireland to distribute their innovative CleanPlex® technology for targeted NGS panel preparation. Our two companies are committed to providing state-of-the-art DNA technologies that advance the utility of genomic testing around the world and are also simple, fast and easy-to-use

FREMONT - Paragon Genomics, a California -based leader in advanced amplicon-based target enrichment solutions for next-generation sequencing (NGS) and precision medicine, today announced a partnership with Devyser, a world leader in diagnostic kits and solutions for advanced DNA testing, to distribute its CleanPlex products and technology in Italy, with the option to expand into additional territories.